2GX4 image
Deposition Date 2006-05-08
Release Date 2007-05-08
Last Version Date 2024-10-23
Entry Detail
PDB ID:
2GX4
Keywords:
Title:
Crystal structure of SARS coronavirus 3CL protease inhibitor complex
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
1.93 Å
R-Value Free:
0.24
R-Value Work:
0.20
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:3C-like proteinase
Chain IDs:A
Chain Length:306
Number of Molecules:1
Biological Source:SARS coronavirus
Ligand Molecules
Primary Citation
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor.
J.Med.Chem. 49 4971 4980 (2006)
PMID: 16884309 DOI: 10.1021/jm0603926

Abstact

A potent SARS coronavirus (CoV) 3CL protease inhibitor (TG-0205221, Ki = 53 nM) has been developed. TG-0205221 showed remarkable activity against SARS CoV and human coronavirus (HCoV) 229E replications by reducing the viral titer by 4.7 log (at 5 microM) for SARS CoV and 5.2 log (at 1.25 microM) for HCoV 229E. The crystal structure of TG-0205221 (resolution = 1.93 A) has revealed a unique binding mode comprising a covalent bond, hydrogen bonds, and numerous hydrophobic interactions. Structural comparisons between TG-0205221 and a natural peptide substrate were also discussed. This information may be applied toward the design of other 3CL protease inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback